Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata

Most common forms of hair loss (alopecia) are caused by aberrant hair follicle cycling and changes in hair follicle morphology. However, current treatments for alopecia do not specifically target these processes. Adipose-derived stromal vascular cells (ADSVCs) that can be harvested from fat cells are one of the latest breakthroughs in the aesthetic field.

Stem Cells in Tx Alopecia May 2018
By |2018-07-16T17:42:33+00:00July 16th, 2018|Alopecia, Hair Restoration, Hearing Loss|Comments Off on Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata

A Spilt Head Study of Efficacy of Placebo versus Plateletrich Plasma Injections in the Treatment of Androgenic Alopecia

Platelet-rich plasma (PRP) is an autologous concentration of human platelets contained in a small volume of plasma with haemostatic and tissue repairing effects. Being enriched by various growth factors, PRP has become the focus of attention in numerous fields of medicine. Androgenic alopecia (AGA) is a common chronic hair loss disorder, characterised by progressive hair loss

PRP vs. Placebo June 2017
By |2018-07-16T17:29:16+00:00July 16th, 2018|Hair Restoration, Hearing Loss, Platelet Rich Plasma – PRP|Comments Off on A Spilt Head Study of Efficacy of Placebo versus Plateletrich Plasma Injections in the Treatment of Androgenic Alopecia

Clinical Safety and Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell Transplantation in Sensorineural Hearing Loss Patients

Hearing loss is a severe disorder affecting communication and quality of life. Numerous studies have demonstrated a consistently negative impact of hearing loss on communication and in addition, it has recently been shown to be a risk factor for dementia.

MSC's in Tx of Sensorineural Hearing Loss
By |2018-07-16T12:44:08+00:00July 16th, 2018|Bone Marrow, Hearing Loss, Mesenchymal Stem Cells|Comments Off on Clinical Safety and Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell Transplantation in Sensorineural Hearing Loss Patients